WVRC Votes to Pursue Legislation for Racing Compact: THA Racing.Com 6/28/17

By: Tom LaMarra The West Virginia Racing Commission June 27 voted to lay the groundwork for legislation that would allow it to become a member of a compact that would facilitate adoption of uniform medication rules. The WVRC took the action in the hope other Mid-Atlantic racing states consider pursuing compact legislation. All racing states

Updated Penalty System Rule Progresses in WV Legislature: THA Racing.Com 2/23/17

By: Tom LaMarra Proposed amendments to Thoroughbred racing rules, including the updated Multiple Medication Violation Penalty System model rule, passed the West Virginia Senate Feb. 17 and await approval by the House of Delegates. West Virginia Racing Commission officials attempted to fast-track the updated MMV rule, which is one of four major components of the

WV Makes Serious Push to Facilitate Quicker Model Rule Adoption: THA Racing.Com 1/24/17

By: Tom LaMarra The West Virginia Racing Commission has agreed to ask state government officials to help facilitate quicker adoption of two important model rules approved by the Association of Racing Commissioners International in December. The WVRC at its Jan. 24 meeting also announced plans to expand its out-of-competition testing program this year beyond the

WVRC to Examine Options for Quicker Adoption of Model Rules: THA Racing.Com 1/10/17

By: Tom LaMarra The West Virginia Racing Commission intends to examine its options in regard to facilitating quicker adoption of national model rules, in particular those related to equine medication and drug testing. West Virginia thus far has been among the more proactive states when it comes to the National Uniform Medication Program, which it has

Accreditation Gets Push in West Virginia: Blood-Horse 8/17/16

By Tom LaMarra West Virginia Racing Commission staff will explore, among other things, whether capital improvement money racetracks get from a video lottery terminal fund can be used to pay for accreditation through the National Thoroughbred Racing Association Safety and Integrity Alliance. The state's two Thoroughbred tracks—Hollywood Casino at Charles Town Races and Mountaineer Casino,

Out-of-Competition Testing Progresses in WV: Blood-Horse 7/19/16

By: Tom LaMarra Regulators and track executives in West Virginia hope to have about 50% of the starters in two upcoming graded stakes tested out of competition as part of a launch of the program in the state. Officials are in the process of determining the likely starters for the $750,000 West Virginia Derby (gr.

WV Moves Ahead With Out-of-Competition Tests: Blood-Horse 6/21/16

By: Tom LaMarra The West Virginia Racing Commission plans to launch its out-of-competition program in conjunction with the $750,000 West Virginia Derby (gr. II) Aug. 6 at Mountaineer Casino, Racetrack & Resort. WVRC executive director Joe Moore June 21 said officials met at Mountaineer "to continue working on (developing) an out-of-competition testing program. The desire is

Indirect Veto Stalls Adoption of WV Rules: Blood-Horse 6/13/16

By: Tom LaMarra Some proposed changes and updates to Thoroughbred racing rules in West Virginia will have to wait almost another year because of an indirect veto by the governor. The Thoroughbred industry in the state each year compiles a wish list of regulatory changes, some of which are tied to updates in the National

WVRC Votes to Hire New Drug-Testing Lab: The Blood-Horse 7/28/15

By Tom LaMarra The West Virginia Racing Commission voted July 28 to hire a new equine drug-testing laboratory when the contract with its current lab ends at the end of August. West Virginia is one of four states in the Mid-Atlantic region that employs Truesdail Laboratories of California; the others are Delaware, Maryland, and New

Mid-Atlantic Issues Advisory on Two Drugs: The Blood-Horse 7/21/15

By Tom LaMarra West Virginia has joined other states in the Mid-Atlantic region in posting an advisory regarding use of two therapeutic drugs that can be problematic for horsemen. The advisory stemmed from a Mid-Atlantic regulatory meeting earlier in July at which the progress of the National Uniform Medication Program was discussed. Participants identified two